Rapid7, Inc

RPD

CIK 0001560327 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$217M
↑+0.5% +$1Mvs FY2024 (Q4)
Operating Income
$2M
↓-37.3% -$1Mvs FY2024 (Q4)
Gross Profit
$150M
↓-0.3% -$384Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
36/100
  • Profitability
    27ROIC 10.4% (10% = solid, 20%+ = moat)
  • Liquidity
    39Current Ratio 1.28 (above 1.5 = solid)
  • Leverage
    100D/E -0.07 (under 0.5 = conservative)
  • Efficiency
    24Asset Turnover 0.51x (1.0+ = capital-efficient)
  • Growth
    18Revenue YoY +0.5% (10% = solid, 25%+ = elite)
  • Margin Trend
    10Op Margin 1.0% · trend -2.4pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project RPD's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

14%

Trailing 3-yr CAGR was 13.5%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$49.29
Total enterprise IV
$3.20B
Diluted shares
0.07B
Terminal PV
$2.39B (75% of total)
Year-5 FCF
$282M
YearProjected FCFDiscounted PV
+1$167M$152M
+2$190M$157M
+3$217M$163M
+4$247M$169M
+5$282M$175M
Terminal$3.85B$2.39B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$8M
investment in PP&E
Stock-based comp (TTM)
$104M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.73B
everything owned
Total liabilities
$1.57B
everything owed
Stockholders' equity
$155M
shareholder claim
Net debt
$-233M
Net cash position ($233M)

Recent performance · 48 quarters

Revenue↑+0.5% +$1M
$217M
Net Income↓-91.2% -$33M
$3M
Free Cash Flow↓-41.8% -$26M
$36M
Operating Margin↓-0.6pts
1.0%

Drill down